Skip to main content
. 2021 Aug 10;2021:3502325. doi: 10.1155/2021/3502325

Table 3.

Mean and standard deviation of the study outcomes.

Outcome Group Time p value
Baseline 6th week 12th week
Weight (kg) Melatonin 82.54 ± 11.63a 80.69 ± 12.16b 80.32 ± 12.48b 0.001
Placebo 78.75 ± 9.83a 75.73 ± 9.35b 75.16 ± 9.53b 0.001
p value 0.35## 0.28## 0.24##
BMI (kg/m2) Melatonin 31.01 ± 2.04a 30.29 ± 1.96b 30.14 ± 2.03b 0.001
Placebo 30.40 ± 1.62a 29.24 ± 1.70b 29.02 ± 2.05b 0.002
p value 0.30# 0.08# 0.10#
Waist circumference (cm) Melatonin 96.47 ± 9.36a 92.63 ± 8.90b 90.79 ± 9.20c 0.001
Placebo 93.74 ± 9.80a 90.16 ± 8.27b 89.37 ± 8.17b 0.001
p value 0.65## 0.38# 0.62#
Body fat mass (%) Melatonin 40.43 ± 5.83a 38.95 ± 6.54a,b 39.10 ± 5.21b 0.196
Placebo 38.21 ± 7.72a 37.34 ± 7.56a 37.09 ± 8.53a 0.234
p value 0.64## 0.55## 0.39#
Physical activity score (met.h/day) Melatonin 38.51 ± 6.41a 39.75 ± 5.43a 40.8 ± 5.59a 0.065
Placebo 39.29 ± 6.16a 42.77 ± 6.54b 40.64 ± 4.92b,a 0.128
p value 0.54## 0.14## 0.93#
Total daily sleep (hour) Melatonin 7.38 ± 1.29a 7.68 ± 1.01a 7.63 ± 1.33a 0.229
Placebo 7.31 ± 1.13a 7.31 ± 0.92a 7.31 ± 0.96a 0.172
p value 0.87# 0.21## 0.41#
Nocturnal saliva melatonin (pgr/mL) Melatonin 18.7 ± 17.44 21.7 ± 18.07 0.629
Placebo 23.43 ± 22.35 16.98 ± 12.58 0.235
p value 0.579## 0.620##
Diurnal saliva melatonin (pgr/mL) Melatonin 13.51 ± 13.71 17.4 ± 16.95 0.286
Placebo 15.13 ± 13.43 16.36 ± 15.74 0.841
p value 0.704## 0.737##
Average saliva melatonin (pgr/mL) Melatonin 16.49 ± 13.37 19.55 ± 14.79 0.44
Placebo 20.03 ± 16.15 16.67 ± 12.19 0.63
p value 0.63## 0.64##

a,b,cThe same letters in two-sided comparisons of a row indicate no significant difference. Nonparametric Friedman test. Repeated measure ANOVA. #Independent sample t-test. ##Nonparametric Mann–Whitney U test. Wilcoxon signed ranks test. ∗∗p value less than 0.05 was considered as significant.